$231.47
0.28% yesterday
NYSE, Dec 24, 09:30 pm CET

Danaher Stock price

$231.47
+4.49 1.98% 1M
+34.00 17.22% 6M
+1.92 0.84% YTD
+0.72 0.31% 1Y
+1.13 0.49% 3Y
+35.14 17.90% 5Y
+168.72 268.89% 10Y
+212.76 1,136.93% 20Y
NYSE, Closing price Wed, Dec 24 2025
+0.64 0.28%

New AI Insights on Danaher Insights AI Insights on Danaher

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$163.5b
Enterprise Value
$178.8b
Net debt
$15.3b
Cash
$1.5b
Shares outstanding
706.3m
Valuation (TTM | estimate)
P/E
47.2 | 29.7
P/S
6.7 | 6.6
EV/Sales
7.4 | 7.2
EV/FCF
35.6
P/B
3.2
Dividends
DPS
$1.28
Yield 1Y | 5Y
0.6% | 0.4%
Growth 1Y | 5Y
18.5% | 14.9%
Payout 1Y | 3Y
20.4% | 13.9%
Increased
12 Years
Financials (TTM | estimate)
Revenue
$24.3b | $24.8b
EBITDA
$7.1b | $7.7b
EBIT
$4.7b | $7.0b
Net Income
$3.5b | $5.5b
Free Cash Flow
$5.0b
Growth (TTM | estimate)
Revenue
2.2% | 3.8%
EBITDA
-2.1% | 1.6%
EBIT
-6.5% | 33.5%
Net Income
-10.0% | 41.2%
Free Cash Flow
0.1%
Margin (TTM | estimate)
Gross
59.6%
EBITDA
29.5% | 31.0%
EBIT
19.5%
Net
14.4% | 22.2%
Free Cash Flow
20.7%
Financial Health
Equity Ratio
63.9%
Return on Equity
7.9%
ROCE
6.4%
ROIC
5.3%
Debt/Equity
0.3
More
EPS
$4.9
FCF per Share
$7.1
Short interest
1.3%
Employees
62k
Rev per Employee
$390.0k
Show more

Is Danaher a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Danaher Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Danaher forecast:

25x Buy
86%
4x Hold
14%

Analyst Opinions

29 Analysts have issued a Danaher forecast:

Buy
86%
Hold
14%

Financial data from Danaher

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
24,268 24,268
2% 2%
100%
- Direct Costs 9,806 9,806
2% 2%
40%
14,462 14,462
2% 2%
60%
- Selling and Administrative Expenses 8,133 8,133
9% 9%
34%
- Research and Development Expense 1,602 1,602
3% 3%
7%
7,146 7,146
2% 2%
29%
- Depreciation and Amortization 2,419 2,419
8% 8%
10%
EBIT (Operating Income) EBIT 4,727 4,727
6% 6%
19%
Net Profit 3,503 3,503
10% 10%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Danaher directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Danaher Stock News

Neutral
PRNewsWire
about 23 hours ago
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Danaher Corporation (NYSE: DHR) breached their fiduciary duties to shareholders.
Neutral
PRNewsWire
8 days ago
WASHINGTON , Dec. 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January 28, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour.
Neutral
Finbold
9 days ago
Jim Cramer, the Mad Money host and former hedge fund manager, is known for his hot financial takes, but some of his latest investment recommendations might still surprise you.
More Danaher News

Company Profile

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Head office United States
CEO Rainer Blair
Employees 62,000
Founded 1984
Website www.danaher.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today